FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WOLTOSZ WALTER S
2. Issuer Name and Ticker or Trading Symbol

SIMULATIONS PLUS INC [ SLP ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

42505 10TH ST. WEST
3. Date of Earliest Transaction (MM/DD/YYYY)

8/26/2019
(Street)

LANCASTER, CA 93534
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Simulations Plus, Inc. common stock  8/26/2019 (1)   S    24000  A $36.22 (2) 5111918  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Automatic sales under 10b5-1 program on 08/26/2019 and 08/27/2019
(2)  On 08/26/2019 15,931 sold at average price of $36.2622 = 577,693.11 On 08/27/2019 8,069 sold at average price of $36.1476 = 291,674.98 Overall average price = 869,368.09/24,000 = $36.2237

Remarks:
Automatic sales under 10b5-1 program

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
WOLTOSZ WALTER S
42505 10TH ST. WEST
LANCASTER, CA 93534
X X

WOLTOSZ VIRGINIA E
42505 10TH STREET WEST
LANCASTER, CA 93534

X


Signatures
Walter S Woltosz 8/28/2019
**Signature of Reporting Person Date

Virginia E Woltosz 8/28/2019
**Signature of Reporting Person Date


Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Simulations Plus Charts.
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Simulations Plus Charts.

Simulations Plus Inc News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
Thursday 4 April 2024 (4 weeks ago) • Business Wire
Exxon Mobil Forecasts Earnings Decline, Twilio Seeks Board Tenure Changes, and More News
Thursday 4 April 2024 (4 weeks ago) • IH Market News
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
Thursday 4 April 2024 (4 weeks ago) • Business Wire
U.S. Futures Dip in Pre-Market, May WTI and June Brent Crude Prices Edge Higher
Wednesday 3 April 2024 (4 weeks ago) • IH Market News
Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date
Thursday 21 March 2024 (1 month ago) • Business Wire
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
Wednesday 13 March 2024 (2 months ago) • Business Wire
Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Simulations Plus and the University of Bath Awarded New FDA Grant
Wednesday 6 March 2024 (2 months ago) • Business Wire
Simulations Plus Extends Collaboration with Major Toxicology Research Agency
Friday 16 February 2024 (3 months ago) • Business Wire
Form 8-K - Current report
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Simulations Plus Launches Corporate Development Initiative
Wednesday 14 February 2024 (3 months ago) • Business Wire